LAB

2.00

0.76% 0.015

Handel nachbörslich: 1.90 -0.10 -5.00%

Standard Biotools Inc (LAB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.985

Offen:

$1.94

24-Stunden-Volumen:

4.48M

Relative Volume:

2.46

Marktkapitalisierung:

$744.52M

Einnahmen:

$106.34M

Nettoeinkommen (Verlust:

$-74.66M

KGV:

-1.8868

EPS:

-1.06

Netto-Cashflow:

$-46.12M

1W Leistung:

+4.71%

1M Leistung:

+24.22%

6M Leistung:

+4.17%

1J Leistung:

+3.63%

1-Tages-Spanne:

$1.895

$2.05

1-Wochen-Bereich:

$1.88

$2.25

52-Wochen-Spanne:

$1.21

$3.04

Standard Biotools Inc Stock (LAB) Company Profile

Firmenname

Standard Biotools Inc

Sektor

Healthcare (1176)

Branche

Medical Devices (148)

Telefon

(650) 266-6000

Adresse

2 TOWER PLACE, SOUTH SAN FRANCISCO

Mitarbeiter

539

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

LAB's Discussions on Twitter

Vergleichen Sie LAB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LAB Standard Biotools Inc	2.00	744.52M	106.34M	-74.66M	-46.12M	-0.95
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-04-16	Eingeleitet	TD Cowen	Buy
2024-04-04	Eingeleitet	Jefferies	Buy
2023-07-12	Eingeleitet	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Aktie (LAB) Neueste Nachrichten

Dec 21, 2024

Standard BioTools Inc. (NASDAQ:LAB) Position Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 21, 2024

Dec 20, 2024

Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Barclays PLC - MarketBeat

Dec 20, 2024

Dec 19, 2024

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Dec 19, 2024

Standard BioTools CEO to Present at J.P. Morgan Healthcare Conference 2024 - StockTitan

Dec 19, 2024

Dec 18, 2024

Standard BioTools (NASDAQ:LAB) Trading Down 6.8%Here's What Happened - MarketBeat

Dec 18, 2024

BNP Paribas Financial Markets Lowers Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World

Dec 18, 2024

Dec 17, 2024

After Leaping 35% Standard BioTools Inc. (NASDAQ:LAB) Shares Are Not Flying Under The Radar - Simply Wall St

Dec 17, 2024

Dec 16, 2024

Standard BioTools (NASDAQ:LAB) Shares Up 9.9%Still a Buy? - MarketBeat

Dec 16, 2024

What Are You Thinking About Investing In Standard BioTools Inc (NASDAQ: LAB) Stock? - Stocks Register

Dec 16, 2024

Dec 14, 2024

Standard BioTools Inc. (NASDAQ:LAB) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat

Dec 14, 2024

Nov 30, 2024

Standard BioTools (STU:FLB) Enterprise Value : €386.4 Mil (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

LAB Stock Price and Chart — NASDAQ:LAB - TradingView

Nov 30, 2024

Standard BioTools Inc. (NASDAQ:LAB) Short Interest Down 24.9% in November - MarketBeat

Nov 30, 2024

Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat

Nov 30, 2024

Nov 28, 2024

Standard BioTools (NASDAQ:LAB) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 59% - Simply Wall St

Nov 28, 2024

Nov 18, 2024

Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Nov 18, 2024

Nov 15, 2024

Indaba Capital Management L.P. Acquires New Stake in Standard Bi - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Creative Planning Purchases Shares of 20,328 Standard BioTools Inc. (NASDAQ:LAB) - Defense World

Nov 14, 2024

Nov 08, 2024

Standard BioTools names new CFO By Investing.com - Investing.com Australia

Nov 08, 2024

ARK Investment Management LLC Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Nov 08, 2024

Nov 07, 2024

Standard BioTools (STU:FLB) Price-to-Operating-Cash-Flow : (As of Nov. 07, 2024) - GuruFocus.com

Nov 07, 2024

Standard BioTools (STU:FLB) Revenue per Share : €0.67 (TTM As of Sep. 2024) - GuruFocus.com

Nov 07, 2024

Standard BioTools Names Co-Founder Alex Kim as CFO, Brings 30-Year Industry Expertise | LAB Stock News - StockTitan

Nov 07, 2024

Nov 06, 2024

Form 10-Q STANDARD BIOTOOLS INC. For: Sep 30 - StreetInsider.com

Nov 06, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Standard BioTools Inc - GuruFocus.com

Nov 05, 2024

Nov 02, 2024

Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 - Yahoo Finance

Nov 02, 2024

Nov 01, 2024

TD Cowen trims Standard BioTools target, sees upside in margins and SomaScan performance - Investing.com Australia

Nov 01, 2024

Standard BioTools Q3 2024 Earnings Preview - MSN

Nov 01, 2024

Standard BioTools Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 01, 2024

Oct 31, 2024

Earnings call: Standard BioTools faces mixed Q3 results amid market challenges - Investing.com Australia

Oct 31, 2024